A variety of treatment approaches targeted at the NF-κB signaling pathway like antioxidants, anti-inflammatory agents, or pharmacologic inhibition revealed effectiveness in experimental AP models. This evidence concerns the gene NFKB1 and alkaline phosphatase measurement.